Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-06

Clinical Trial Update: Observation Study on the Efficacy of Yiqi Gubiao Pill in the Treatment of Chronic Obstructive Pulmonary Disease Secondary to Active Pulmonary Tuberculosis [EARLY_Phase 1]

View source ↗

Summary

An early-phase observational study assessing Yiqi Gubiao Pill for chronic obstructive pulmonary disease secondary to active pulmonary tuberculosis. The trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yiqi Gubiao Pill

Snippet

Sponsor: Fourth Affiliated Hospital of Xinjiang Medical University | Conditions: Tuberculosis-related Obstructive Pulmonary Disease | EARLY_Phase 1 | Status: NOT_YET_RECRUITING